These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25547444)

  • 1. [The impact of pre-primary percutaneous coronary intervention β blocker use on the no-reflow phenomenon in patients with acute myocardial infarction].
    Wang J; Chen Y; Wang C; Zhu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Oct; 42(10):822-6. PubMed ID: 25547444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
    Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
    Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
    Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of the no-reflow phenomenon after primary percutaneous coronary intervention for acute myocardial infarction].
    Zhao Y; Chen Y; Tian F; Wang C; Hu S; Wang J; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):261-4. PubMed ID: 22381773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kurtul A; Yarlioglues M; Celik IE; Duran M; Elcik D; Kilic A; Oksuz F; Murat SN
    Coron Artery Dis; 2015 Dec; 26(8):706-12. PubMed ID: 26340546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Al-Jabari AMK; Elserafy AS; Abuemara HZA
    Egypt Heart J; 2017 Sep; 69(3):171-175. PubMed ID: 29622973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction.
    Endo M; Hibi K; Shimizu T; Komura N; Kusama I; Otsuka F; Mitsuhashi T; Iwahashi N; Okuda J; Tsukahara K; Kosuge M; Ebina T; Umemura S; Kimura K
    JACC Cardiovasc Interv; 2010 May; 3(5):540-9. PubMed ID: 20488411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.
    Zhang H; Qiu B; Zhang Y; Cao Y; Zhang X; Wu Z; Wang S; Mei L
    Med Sci Monit; 2018 Jul; 24():4528-4535. PubMed ID: 29961077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Aggarwal P; Rekwal L; Sinha SK; Nath RK; Khanra D; Singh AP
    Ann Cardiol Angeiol (Paris); 2021 Jun; 70(3):136-142. PubMed ID: 33962782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of the TIMI risk index on admission for predicting angiographic no-reflow after primary percutaneous coronary intervention in patients with STEMI.
    Acet H; Ertaş F; Akil MA; Bilik MZ; Aydin M; Polat N; Yildiz A
    Turk J Med Sci; 2016 Apr; 46(3):604-13. PubMed ID: 27513233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
    Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
    Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions.
    Jiecheng P; Ai-Ling W
    Perfusion; 2016 May; 31(4):300-6. PubMed ID: 26354739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L
    Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Sen N; Afsar B; Ozcan F; Buyukkaya E; Isleyen A; Akcay AB; Yuzgecer H; Kurt M; Karakas MF; Basar N; Hajro E; Kanbay M
    Atherosclerosis; 2013 May; 228(1):203-10. PubMed ID: 23489347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.